HHS now lets pharmacies compound BPC-157, TB-500 and four others, but BoxingInsider notes all six remain on WADA's banned list for licensed boxers.
Recap by typeshit. Full story at BoxingInsider.com.
The peptide item sits among gene therapy, Neuralink and Medicare news. The Alliance for Safe Biologic Medicines has asked HHS to pause the policy, citing FDA scientists.
Maria David Patten alleges Novo hid NAION risks; her case joins the federal MDL before Judge Karen Marston in Pennsylvania, where bellwether trials are expected.
Politico looks at the warning signs around Health Secretary Kennedy's move to let six peptides that lack FDA approval reach the US market.
Per @pamelajeannoble, the letter flags contamination risks, manufacturing conditions and compounded copies resembling approved drugs.
The Korean drugmaker, which co-promotes Wegovy with Novo Nordisk locally, credits the obesity drug for operating profit of 23.7 billion won, though net profit fell.
The Houston compounding firm is pulling its tirzepatide and niacinamide injection because sterility couldn't be assured, and the vials had shipped nationwide.
Loading…